Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Methicillin

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Microneedle patch with precise vancomycin drug dose against MRSA skin infections
    Microneedle patch with precise vancomycin drug dose against MRSA skin infections

    04 Jan 2022

    // Georgios A Sotiriou EUROPEANPHARMACEUTICALREVIEW

    https://www.europeanpharmaceuticalreview.com/article/167178/microneedle-patch-with-precise-vancomycin-drug-dose-against-mrsa-skin-infections/

    Georgios A Sotiriou EUROPEANPHARMACEUTICALREVIEW
    04 Jan 2022
    Share Share
    Bausch + Lomb Announces Publication Of 10-Year Armor Study Results
    Bausch + Lomb Announces Publication Of 10-Year Armor Study Results

    14 Apr 2020

    // EYEWIRE

    https://eyewire.news/articles/bausch-lomb-announces-publication-of-10-year-armor-study-results-on-ocular-antibiotic-resistance/

    EYEWIRE
    14 Apr 2020
    Share Share
    Melinta Therapeutics Launches Antibiotic Baxdela™ (delafloxacin) in the US
    Melinta Therapeutics Launches Antibiotic Baxdela™ (delafloxacin) in the US

    29 Jan 2018

    // PRESS RELEASE

    http://ir.melinta.com/news-releases/news-release-details/melinta-therapeutics-launches-antibiotic-baxdelatm-delafloxacin

    PRESS RELEASE
    29 Jan 2018
    Share Share